Review Article

Theranostic Implications of Nanotechnology in Multiple Sclerosis: A Future Perspective

Figure 5

Multivariate nanocarriers. (a) multipartite nanostructure with targeting agent, permeation enhancer for BBB and RES, and multicomponent theranostic agent. PEGylation strategy for QDs for increasing uptake and combating BBB (b). (c) demonstrates interaction of neurons with the CNTs and fluorescently labelled neurons interaction with nanostructured surfaces.
160830.fig.005a
(a)
160830.fig.005b
(b)
160830.fig.005c
(c)